Clinical trials
Completed Observational Pneumococcal Infections trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2005 | 3 |
| 2006 | 3 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 4 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 1 |
| 2019 | 1 |
| 2022 | 2 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 32 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 9 |
| Wyeth is now a wholly owned subsidiary of Pfizer | 7 |
| Arto Palmu | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Centre Hospitalier Princesse Grace | 1 |
| Finnish Institute for Health and Welfare | 1 |
| GlaxoSmithKline | 1 |
| Institut National de la Santé Et de la Recherche Médicale, France | 1 |
| Johns Hopkins Bloomberg School of Public Health | 1 |
| Meridian Bioscience, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pneumococcal Infections | 32 |
| Pneumonia | 4 |
| Community-Acquired Pneumonia | 3 |
| AIDS-Related Opportunistic Infections | 1 |
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 |
| Emergencies | 1 |
| HIV Infections | 1 |
| Mycobacterium avium-intracellulare Infection | 1 |
| Otitis Media | 1 |
| Otitis Media with Effusion | 1 |
Trials
Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.